This research is just a continuation of data we already are aware of that was published several years ago, that there is a distinct survival advantage in
HPV+ patients. This paper just extends the length of the survival time since the original paper was published. You can always pass these things by the OCF office first, and certainly look for them in the OCF OC RSS news feed, which is FREE and you should subscribe to since it puts up, as they become available, the most current stories from hard science to human interest as it relates to OC. It is good to care that others are informed, just please check the news feed first to see if it is already there in the history or current articles.